Rapid Biopharma

Bengaluru, India
Specializes in the formulation of generic pharmaceuticals.

About Rapid Biopharma

Rapid Biopharma is a Healthcare company based in Bengaluru (India) by D S Harinath. It specializes in the formulation of generic pharmaceuticals. It operates on a B2B model. Its Indian entity Rapid Biopharma Private Limited reported revenue of β‚Ή3.33 Cr. Its focus areas include Pharmaceuticals, Generics Manufacturing and Formulation Development.

Company details

Rapid Biopharma operates with a B2B model, focusing on providing healthcare solutions, producing pharmaceutical products, generics manufacturing, and formulation development. Specializes in the formulation of generic pharmaceuticals. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.

Key Metrics
  • Annual Revenue
    ₹3.33 Cr

    FY 2025 · +9% YoY

  • Net Profit
    ₹85,390

    FY 2025 · 0% margin

  • EBITDA
    ₹1.3 Lakh

    FY 2025 · 0% margin

Board of directors of Rapid Biopharma Private Limited (Rapid Biopharma)

Rapid Biopharma Private Limited is the primary company behind Rapid Biopharma. The board of Rapid Biopharma Private Limited currently have 4 directors; the longest-serving is Dasagrandhi Subramanyam Harinath, appointed in 2011. 3 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Dasagrandhi Subramanyam Harinath
DIN 03609959
Director31 Oct 201115 yrsRapid Biopharma Private Limited
Dasagrandhi Madhuri
DIN 07200272
Director25 Mar 201511 yrs 7 moRapid Biopharma Private Limited
Vijaya Bhaskar Gooty
DIN 07198882
Director10 Apr 201511 yrs 7 moRapid Biopharma Private Limited
Dasagranthi Shanmugam Suresh Kumar
DIN 07200276
Director10 Apr 201511 yrs 7 moRapid Biopharma Private Limited

People of Rapid Biopharma

1 people are tracked at Rapid Biopharma (1 in leadership).

NameRoleGroup
D S Harinath
FounderLeadership
Premium access

Complete people profiles for Rapid Biopharma

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Rapid Biopharma

Figures of Rapid Biopharma Private Limited, the primary company behind Rapid Biopharma, for FY 2025. Revenue was ₹3.33 Cr (+9% year on year). Net profit was ₹85,390 (0% margin). EBITDA was ₹1.3 Lakh (0% margin). Revenue has grown at a compounded annual rate of +16% over three years and +11% over five years.

  • ₹3.33 CrRevenue · FY 2025 · +9% YoY
  • ₹85,390Net profit · 0% margin
  • ₹1.3 LakhEBITDA · 0% margin
  • ₹62 LakhPaid-up capital
  • +16%Revenue CAGR, 3 years
  • +11%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Rapid Biopharma Private Limited are on its company page.

Premium access

Detailed financial statements for Rapid Biopharma

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Rapid Biopharma

Rapid Biopharma is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.

The primary company behind Rapid Biopharma, Rapid Biopharma Private Limited, reported revenue of β‚Ή3.33 Cr for FY 2025, up 9% year on year.

Rapid Biopharma operates with a B2B model, focusing on providing healthcare solutions, producing pharmaceutical products, generics manufacturing, and formulation development. Specializes in the formulation of generic pharmaceuticals. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.

Rapid Biopharma operates through Rapid Biopharma Private Limited.

The legal entities of Rapid Biopharma currently have 4 directors, including Dasagrandhi Subramanyam Harinath, Vijaya Bhaskar Gooty, Dasagrandhi Madhuri and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available